Industry news

Popular Tags

industry life COVID-19 FDA science research Hi-Tech medical technology medindustriya business WHO Trump cancer law Alzheimer's disease Industry homeopathy Alzheimer medical brain medicine investment hepatitis c medical and health genome Alzheimer's multiple sclerosis human brain DNA digital biomarkers Nobel Prize medicine and health Parkinson’s disease diabetes hacker attack Amazon startup biology 3D printing biotechnology charity tecnolgy coronavirus cyber-security vaccine health

June 18, 2020, 14:59

WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients

The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.

WHO COVID-19

Site Map